Nordson Corporation (NDSN)
POSITIVEFundamental
70
Kurs
$334.96
Marktkapitalisierung
$18.51B
Teil 1 · Was das Unternehmen wert ist
Übersicht
Nordson makes precision dispensing equipment: machines that apply exact, controlled amounts of adhesives, coatings, sealants and other fluids inside a factory line, plus components used in medical devices and semiconductor manufacturing. Its products are typically a small line item inside a much larger production process — a diaper plant's glue applicator, a chip packaging step, a catheter's plastic tubing — but a failure or imprecision there can shut the whole line down.
Wie das Geld verdient wird
Revenue comes mostly from selling dispensing systems and components once, plus recurring sales of spare parts, nozzles and service that keep those systems running precisely over years of use. Because customers integrate Nordson's equipment into a validated production process, replacing it later requires re-qualifying the whole line, which supports steady repeat business rather than one-off equipment sales.
Umsatz nach Segment
Adhesive, coating and sealant dispensing systems sold into packaging, general industrial and consumer goods production lines.
Components and precision fluid-management systems used in medical devices such as catheters, plus fluid dispensing for other industries.
Equipment used in semiconductor and electronics manufacturing, including chip packaging and testing steps.
Wettbewerbsvorteil
Wechselkosten · SchmalOnce a customer validates a production line around Nordson's dispensing equipment — calibrated to exact fluid volumes and tolerances, sometimes under regulatory approval as in medical devices — swapping to a competitor means re-validating the whole line, a costly and slow process manufacturers avoid unless something is badly wrong. That keeps replacement parts and service revenue sticky even where the original equipment sale was competitive.
Was die Nachfrage antreibt
Mäßig zyklischDemand splits between steadier end markets — packaging, medical devices, consumer nondurables — and more cyclical ones like semiconductor and electronics capital spending, which swings with chip industry investment cycles. The mix of the three segments smooths some of that cyclicality but does not remove it, particularly in the Advanced Technology segment.
Wichtigste Risiken
- Cyclicality in semiconductor capital spending — The Advanced Technology Solutions segment depends on chip makers' capital equipment budgets, which are historically volatile and can swing sharply between shortage and oversupply periods.
- Acquisition integration risk — Nordson has grown its segments partly through acquisitions; integrating acquired businesses' operations, systems and customer relationships carries execution risk and can strain expected returns.
- Customer capital spending decisions — Equipment sales depend on customers deciding to build or upgrade production lines, decisions that can be postponed in an uncertain economic environment even when replacement parts demand continues.
- International operations and currency exposure — A significant share of sales and manufacturing occurs outside the United States, exposing results to currency translation and to economic and trade conditions in those markets.
Die Argumente dafür
Buyers argue that Nordson's equipment gets embedded in validated production lines across three diversified end markets, that recurring parts and service revenue smooths the cycle, and that record fiscal 2025 results show the model compounding through both steadier and more cyclical segments at once.
Die Argumente dagegen
Sellers fear that the Advanced Technology segment remains exposed to a genuinely volatile semiconductor capital-spending cycle, that growth built partly through acquisitions carries integration risk that can disappoint, and that a broader industrial slowdown would delay the equipment upgrades that drive the larger, steadier segments too.
Written by the editors, published on 18. August 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilanz & Liquidität
Umsatz
$2.98B
Letzte 12 Monate (bis 31.7.2026)
Nettogewinn
$555M
Letzte 12 Monate (bis 31.7.2026)
Freier Cashflow
$661M
Gesamtes Eigenkapital
$3.04B
Gesamtverbindlichkeiten
$2.87B
Current Ratio
1.82
Zinsdeckungsgrad
8.83
Schulden/EBITDA
2.30
Gewinn je Aktie
Umsatz & Nettogewinn
Freier Cashflow
Ertragsaufschlüsselung
Historische Aufstellung
Margen im Zeitverlauf
Verschuldung im Zeitverlauf
Wie schwer die Schulden wiegen
Wachstumsraster
Wachstum — Umsatz
Innerer-Wert-Schätzung
Innerer Wert
$291.28
Aktueller Kurs
$334.96
Sicherheitsmarge
-15.0%
Innerer-Wert-Spanne
$219.91 - $362.64
Bewertungsmethoden
Bewertungskennzahlen
P/E-Verhältnis
33.83
ROE
15.9%
P/B-Verhältnis
5.69
P/FCF
25.69
Bruttomarge
55.3%
ROIC
12.1%
Rentabilitäts-Radar
Value Creation (Economic Moat)
ROIC
12.1%
WACC
9.5%
ROIC − WACC
+2.6 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Fundamentalanalyse-Kriterien
Bestanden (21)
- EPS shows upward trend
- EPS CAGR 5.49%
- Price CAGR 11.48%
- ROIC 12.1%
- Gross Margin 55.3%
- P/FCF 25.69
- Debt/Equity ratio
- Operating Margin 26.9%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 17.1%
- Revenue Growth 5Y 5.7%
- Analyst Consensus 67% Buy
- Earnings Quality (OCF/NI) 1.39
- Share Dilution -1.2%
- Net Margin Trend 18.6% vs 16.3%
- Piotroski F-Score 7/9
Nicht bestanden (6)
- P/B Ratio 5.69
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.3%
- PEG Ratio 2.19
Nicht verfügbar (1)
- Dividend Payout NaN%
Piotroski F-Score
Starke finanzielle Gesundheit
Gewinnqualität
Hohe Qualität: Gewinne durch Cashflow gedeckt
Aktienverwässerung
Aktienrückkäufe. Aktionärsfreundlich
Unternehmensführung
Führungsteam
| Name | Position | Alter |
|---|---|---|
| Mr. Sundaram Nagarajan | President, CEO & Director | 62 |
| Mr. Daniel R. Hopgood | Executive VP & CFO | 52 |
| Ms. Jennifer L. McDonough J.D. | Executive VP, General Counsel & Corporate Secretary | 53 |
| Mr. Joseph P. Kelley | Executive VP of Industrial Precision Solutions Leader | 52 |
| Mr. Joseph M. Rutledge | VP & Chief Accounting Officer | 45 |
| Ms. Lara L. Mahoney | Vice President of Investor Relations & Corporate Communications | - |
| Katie Colacarro | Vice President of Corporate Development | - |
| Ms. Sarah Siddiqui | Executive VP & Chief Human Resources Officer | 47 |
| Mr. Justin Hall | Executive Vice President of Medical & Fluid Solutions | 46 |
Prüfungsrisiko
9
Vorstandsrisiko
3
Vergütungsrisiko
6
Aktionärsrechterisiko
10
Teil 2 · Der Preis und der Einstiegszeitpunkt
Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.
Latest News
Recent headlines for NDSN, sourced from Markets Gazette.
- 4d agoPOSITIVEThursday’s Activity, 4 Possible Friday Plays
Nordson Corporation (NDSN) was highlighted as a potential multi-bagger opportunity in Thursday's trading session, with the NDSN Weekly $310-320 call options showing significant upside potential. The article suggests that the stock has delivered strong performance, aligning with the firm's successful track record of identifying profitable trading plays. Investors who followed this recommendation may have seen substantial gains, indicating positive momentum for the company's stock.
via Markets Gazette